Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Special https://ift.tt/3nX8fwP
Subscribe to:
Post Comments (Atom)
Amber Discovered For the First Time in Antarctica: What You Need to Know
The discovery of amber in Antarctica has been reported for the first time, as detailed in a recent study published in Antarctic Science. Dr...
-
A fascinating member of Telangana cabinet is Maoist-turned-MLA Danasari Anasuya, popularly known as Seethakka, whom Chief Minister Revanth R...
-
It was a photo-op moment to melt the stoniest of hearts. The Khans attended the gala opening of the Nita Mukesh Ambani Cultural Centre in Mu...
No comments:
Post a Comment